IIT researchers develop promising TB diagnostics solution
Ravi Elangovan’s decision to leave a cushy research job in Florence and join IIT-Delhi’s faculty in 2010 was driven mostly by personal reasons.
Johnson and Johnson to offer first TB drug in 40 years for $900
US drug maker Johnson and Johnson will offer its new tuberculosis (TB) drug, Bedaquiline, at $900 (Rs 70,000) once its conditional access programme with the government of India ends in 2019, the company said in an interview to ET.
Scientists are developing an eye drop to treat age-related vision loss
LONDON: Scientists are developing an eye drop that could revolutionise the treatment for age-related macular degeneration (AMD), the leading cause of blindness in the developed world.
A Diet Rich in Nuts May Boost Sperm Count and Motility: Stud
For men planning for fatherhood, regularly consuming a good of nuts can significantly improve men’s firtility and sperm mobility.
Aminex Therapeutics Initiates First Clinical Trial of Novel Immunotherapy AMXT 1501 + DFMO in Cancer Patients
Aminex Therapeutics, Inc., a clinical-stage drug development company focused on advancing a novel cancer immunotherapy, announced it received clearance from the FDA to initiate the first Phase 1 clinical trial of its immuno-oncology drug candidate AMXT 1501.